TRK-750
- Generic Name
- TRK-750
Safety, Tolerability, Pharmacokinetics (PK), Pharmacodynamics (PD), Food-effect of TRK-750
Phase 1
Completed
- Conditions
- Healthy, Peripheral Neuropathic Pain
- Interventions
- Drug: Placebo
- First Posted Date
- 2017-11-17
- Last Posted Date
- 2018-12-19
- Lead Sponsor
- Toray Industries, Inc
- Target Recruit Count
- 105
- Registration Number
- NCT03346330
- Locations
- 🇬🇧
London, London, United Kingdom
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.
© Copyright 2025. All Rights Reserved by MedPath